China · Delayed Price · Currency is CNY G1 Therapeutics Statistics
Total Valuation
SHA:605277 has a market cap or net worth of CNY 8.16 billion. The enterprise value is 9.04 billion.
| Market Cap | 8.16B |
| Enterprise Value | 9.04B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
SHA:605277 has 322.06 million shares outstanding. The number of shares has decreased by -2.22% in one year.
| Current Share Class | 322.06M |
| Shares Outstanding | 322.06M |
| Shares Change (YoY) | -2.22% |
| Shares Change (QoQ) | -3.41% |
| Owned by Insiders (%) | 50.10% |
| Owned by Institutions (%) | 1.61% |
| Float | 148.34M |
Valuation Ratios
The trailing PE ratio is 49.70.
| PE Ratio | 49.70 |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| PB Ratio | 5.36 |
| P/TBV Ratio | 6.17 |
| P/FCF Ratio | 157.40 |
| P/OCF Ratio | 79.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.70, with an EV/FCF ratio of 174.24.
| EV / Earnings | 56.29 |
| EV / Sales | 2.43 |
| EV / EBITDA | 30.70 |
| EV / EBIT | 46.25 |
| EV / FCF | 174.24 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.33 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 4.31 |
| Debt / FCF | 24.44 |
| Interest Coverage | 7.91 |
Financial Efficiency
Return on equity (ROE) is 11.05% and return on invested capital (ROIC) is 4.53%.
| Return on Equity (ROE) | 11.05% |
| Return on Assets (ROA) | 3.63% |
| Return on Invested Capital (ROIC) | 4.53% |
| Return on Capital Employed (ROCE) | 10.10% |
| Revenue Per Employee | 2.13M |
| Profits Per Employee | 91,745 |
| Employee Count | 1,750 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 5.89 |
Taxes
In the past 12 months, SHA:605277 has paid 13.21 million in taxes.
| Income Tax | 13.21M |
| Effective Tax Rate | 7.60% |
Stock Price Statistics
The stock price has increased by +100.24% in the last 52 weeks. The beta is 0.42, so SHA:605277's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +100.24% |
| 50-Day Moving Average | 20.78 |
| 200-Day Moving Average | 16.67 |
| Relative Strength Index (RSI) | 52.94 |
| Average Volume (20 Days) | 41,547,381 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605277 had revenue of CNY 3.72 billion and earned 160.55 million in profits. Earnings per share was 0.51.
| Revenue | 3.72B |
| Gross Profit | 528.92M |
| Operating Income | 195.42M |
| Pretax Income | 173.77M |
| Net Income | 160.55M |
| EBITDA | 266.52M |
| EBIT | 195.42M |
| Earnings Per Share (EPS) | 0.51 |
Balance Sheet
The company has 394.25 million in cash and 1.27 billion in debt, giving a net cash position of -873.32 million or -2.71 per share.
| Cash & Cash Equivalents | 394.25M |
| Total Debt | 1.27B |
| Net Cash | -873.32M |
| Net Cash Per Share | -2.71 |
| Equity (Book Value) | 1.52B |
| Book Value Per Share | 4.83 |
| Working Capital | 544.18M |
Cash Flow
In the last 12 months, operating cash flow was 103.04 million and capital expenditures -51.17 million, giving a free cash flow of 51.87 million.
| Operating Cash Flow | 103.04M |
| Capital Expenditures | -51.17M |
| Free Cash Flow | 51.87M |
| FCF Per Share | 0.16 |
Margins
Gross margin is 14.22%, with operating and profit margins of 5.25% and 4.32%.
| Gross Margin | 14.22% |
| Operating Margin | 5.25% |
| Pretax Margin | 4.67% |
| Profit Margin | 4.32% |
| EBITDA Margin | 7.16% |
| EBIT Margin | 5.25% |
| FCF Margin | 1.39% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.59%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.70% |
| Buyback Yield | 2.22% |
| Shareholder Yield | 2.78% |
| Earnings Yield | 1.97% |
| FCF Yield | 0.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 13, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 13, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
SHA:605277 has an Altman Z-Score of 2.96 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.96 |
| Piotroski F-Score | 5 |